Literature DB >> 26438496

3-Halo Chloroquine Derivatives Overcome Plasmodium falciparum Chloroquine Resistance Transporter-Mediated Drug Resistance in P. falciparum.

Sonia Edaye1, Dagobert Tazoo2, D Scott Bohle2, Elias Georges3.   

Abstract

Polymorphism in the Plasmodium falciparum chloroquine resistance transporter (PfCRT) was shown to cause chloroquine resistance. In this report, we examined the antimalarial potential of novel 3-halo chloroquine derivatives (3-chloro, 3-bromo, and 3-iodo) against chloroquine-susceptible and -resistant P. falciparum. All three derivatives inhibited the proliferation of P. falciparum; with 3-iodo chloroquine being most effective. Moreover, 3-iodo chloroquine was highly effective at potentiating and reversing chloroquine toxicity of drug-susceptible and -resistant P. falciparum.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26438496      PMCID: PMC4649156          DOI: 10.1128/AAC.01139-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position.

Authors:  Catherine H Kaschula; Timothy J Egan; Roger Hunter; Nicoletta Basilico; Silvia Parapini; Donatella Taramelli; Erica Pasini; Diego Monti
Journal:  J Med Chem       Date:  2002-08-01       Impact factor: 7.446

2.  Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas.

Authors:  Kekeli Ekoue-Kovi; Kimberly Yearick; Daniel P Iwaniuk; Jayakumar K Natarajan; John Alumasa; Angel C de Dios; Paul D Roepe; Christian Wolf
Journal:  Bioorg Med Chem       Date:  2008-11-12       Impact factor: 3.641

3.  Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity.

Authors:  T J Egan; R Hunter; C H Kaschula; H M Marques; A Misplon; J Walden
Journal:  J Med Chem       Date:  2000-01-27       Impact factor: 7.446

Review 4.  PfCRT and its role in antimalarial drug resistance.

Authors:  Andrea Ecker; Adele M Lehane; Jérôme Clain; David A Fidock
Journal:  Trends Parasitol       Date:  2012-09-25

5.  Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum.

Authors:  Patrick G Bray; Samantha Deed; Emma Fox; Martha Kalkanidis; Mathirut Mungthin; Leslie W Deady; Leann Tilley
Journal:  Biochem Pharmacol       Date:  2005-10-15       Impact factor: 5.858

6.  Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.

Authors:  Fabián E Sáenz; Tina Mutka; Kenneth Udenze; Ayoade M J Oduola; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2012-06-18       Impact factor: 5.191

7.  Reversal agent and linker variants of reversed chloroquines: activities against Plasmodium falciparum.

Authors:  Simeon Andrews; Steven J Burgess; Deborah Skaalrud; Jane Xu Kelly; David H Peyton
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

8.  Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines.

Authors:  Kimberly Yearick; Kekeli Ekoue-Kovi; Daniel P Iwaniuk; Jayakumar K Natarajan; John Alumasa; Angel C de Dios; Paul D Roepe; Christian Wolf
Journal:  J Med Chem       Date:  2008-03-18       Impact factor: 7.446

9.  Quinine dimers are potent inhibitors of the Plasmodium falciparum chloroquine resistance transporter and are active against quinoline-resistant P. falciparum.

Authors:  Christine A Hrycyna; Robert L Summers; Adele M Lehane; Marcos M Pires; Hilda Namanja; Kelsey Bohn; Jerrin Kuriakose; Michael Ferdig; Philipp P Henrich; David A Fidock; Kiaran Kirk; Jean Chmielewski; Rowena E Martin
Journal:  ACS Chem Biol       Date:  2014-01-06       Impact factor: 5.100

10.  To kill or not to kill, that is the question: cytocidal antimalarial drug resistance.

Authors:  Paul D Roepe
Journal:  Trends Parasitol       Date:  2014-02-13
View more
  1 in total

Review 1.  Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.

Authors:  Zi-Ning Lei; Zhuo-Xun Wu; Shaowei Dong; Dong-Hua Yang; Litu Zhang; Zunfu Ke; Chang Zou; Zhe-Sheng Chen
Journal:  Pharmacol Ther       Date:  2020-09-08       Impact factor: 12.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.